Mikkel Lykke Larsen

Mikkel Lykke Larsen has a diverse work experience spanning various industries. Mikkel Lykke started their career as a Research & Analysis professional at GES Investment Services in 2003. Mikkel Lykke then moved on to work as a Business Development Consultant at TTO, specializing in technology transfer and IPR management. In 2008, they joined Implement A/S as a Management Consultant before transitioning to Novo Nordisk in 2009 as a Lead Negotiator, responsible for global agreements and contracts. Larsen then joined Rolls-Royce in 2011 as a Strategic Purchasing Executive, where they managed multiple transformation programs, resulting in significant annual savings. Mikkel Lykke later worked at Maersk Group as a Group Procurement Director, overseeing procurement operations until 2016. Since then, they have been associated with PFA, where they have held various positions including Chief Procurement Officer, Sales Director, and currently serves as the Director of Health.

Mikkel Lykke Larsen attended the Harvard Medical School in 2023. Before that, they completed their B2B Pricing Excellence degree at IMD in 2017. Mikkel earned their M.Sc degree in Innovation & Business Development from the Copenhagen Business School between 2000 and 2005. In 2003, they also briefly studied Business & Economics at the Questrom School of Business, Boston University.